Boehringer Ingelheim will expand its pipeline in nonalcoholic steatohepatitis (NASH) and related liver diseases by partnering with Yuhan to develop a first-in-class dual agonist, the companies said, through a collaboration that could generate more than $870 million for the South Korean pharma
To determine the effect of GLP-1RA, the researchers injected exenatide into the mices abdomen (peritoneum)
(India), Lupin Limited (India), Zydus Lifesciences (India), Torrent Pharmaceuticals (India), Glenmark Pharmaceuticals (India), Alkem Laboratories (India), Natco Pharma (India), MSN Laboratories (India), Eris Lifesciences (India), Emcure Pharmaceuticals (India), Samsung Bioepis Co., Ltd
Document your experience to support the refund request if needed